Cell line · CVCL_0425
MEG-01
Cancer cell line, Homo sapiens. Blast phase chronic myelogenous leukemia, BCR-ABL1 positive. 33 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. MEG-01. Cell lines, record CVCL_0425. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0425
On this page
Cell line
As Cellosaurus gives it.
- Name
- MEG-01
- Accession
- CVCL_0425
- RRID
- RRID:CVCL_0425
- Synonyms
- Meg-01, MEG01, Meg01
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 55Y
- Category
- Cancer cell line
- Diseases
- Blast phase chronic myelogenous leukemia, BCR-ABL1 positive (NCIt C9110); Chronic myeloid leukemia (ORDO Orphanet_521)
- Derived from
- Bone marrow (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers33
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Molecular and functional analysis of calcium binding by a cancer-linked calreticulin mutant. | Elife | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MYH9 mutations differentially stabilize non-muscle myosin II filaments and induce distinct cellular aggregation phenotypes. | Cell Mol Life Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The Disordered Region of ASXL1 Acts as an Auto-Regulator Through Condensation. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Afatinib exerts an inhibitory effect on T cell-mediated cytotoxicity. | Cancer Immunol Immunother | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Molecular Control of Non-Muscle Myosin II-A Aggregation and Intracellular Dynamics by motor- or tail-specific MYH9 Mutations. | bioRxiv | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Oncogenic KRASG12D Transfer from Platelet-like Particles Enhances Proliferation and Survival in Non-Small Cell Lung Cancer Cells. | Int J Mol Sci | 2025 | Its Methods give the RRID and name the line | PubMed | |
| LncRNA IRAIN overcomes imatinib resistance in chronic myeloid leukemia via NF-κB/CD44 pathway inhibition. | iScience | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasms. | Cell Rep | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research. | Int J Mol Sci | 2023 | Cellosaurus cites it | PubMed | |
| Pan-cancer proteomic map of 949 human cell lines. | Cancer Cell | 2022 | Cellosaurus cites it | PubMed |
1 to 10 of 33
See all 33 papersRelatives4
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | HyCyte MEG-01 KO-hCST7 | CVCL_F4H4 | Cell lines | |
| Derived from it | HyCyte MEG-01 hJAK2_p.V617F_c.1849G>T | CVCL_E2Q6 | Cell lines | |
| Derived from it | MEG-01s | CVCL_3022 | Cell lines | |
| Derived from it | SPYMEG | CVCL_VG38 | Cell lines |
Cell banks8
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0425
GET https://conductscience.org/api/cell-lines/v1/CVCL_0425/papers?page=2